van Hylckama Vlieg Johan 4
4 · Kaleido Biosciences, Inc. · Filed Jan 18, 2022
Insider Transaction Report
Form 4
van Hylckama Vlieg Johan
Chief Scientific Officer
Transactions
- Award
Restricted Stock Units
2022-01-14+350,000→ 350,000 total→ Common Stock (350,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
- [F2]The restricted stock units shall vest on the earlier of 50% on January 14, 2023 and 50% on January 14, 2024 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer.